Prevention of neuronal apoptotic death by neurotrophic agents and ganglioside GM1: Insights and speculations regarding a common mechanism

Perspectives on Developmental Neurobiology

Volumn 3, Issue 2, 1996, Pages 93-100

  Ferrari, Giovanna ^a,b   Greene, Lloyd A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Fidia Advanced Biopolymers   (Italy)

Author keywords

Apoptosis; GM1; Nerve growth factor; Neurotrophins, gangliosides

Indexed keywords

GANGLIOSIDE GM1; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROPROTECTIVE AGENT; PROTEIN TYROSINE KINASE;

ANIMAL; APOPTOSIS; DRUG EFFECT; HUMAN; NERVE CELL; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; G(M1) GANGLIOSIDE; HUMANS; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, NERVE GROWTH FACTOR;

EID: 0029680615     PISSN: 10640517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Gorio, A. (1986). Ganglioside enhancement of neuronal differentiation, plasticity and repair. CRC Crit. Rev. Clin. Neurobiol. 2, 241-296.
2. Cuello, A. C., Garofalo, L., Kenigsberg, R. L., and Maysinger, D. (1989). Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc. Natl. Acad. Sci. USA 86, 2056-2060.
3. Skaper, S. D., Leon, A., and Toffano, G. (1989). Ganglioside function in the development and repair of the nervous system. Mol. Neurobiol. 3, 173-199.
4. Skaper, S. D., Facci, L., Milani, D., and Leon, A. (1989). Monosialo-ganglioside GM1 protects against anoxia-induced neuronal death in vitro. Exp. Neurol. 106, 297-305.
5. Karpiak, S. E., Mahadik, S. P., and Wakade, C. G. (1990). Ganglioside reduction of ischemic injury. CRC Crit. Rev. Neurobiol. 5, 221-237.
6. Manev, H., Favaron, M., Vicini, S., and Guidotti, A. (1990). Ganglioside-mediated protection from glutamate-induced neuronal death. Acta Neurobiol. Exp. 50, 475-488.
7. Cuello, A. C. (1990). Gangliosphingolipids that can regulate nerve growth and repair. Adv. Pharmacol. 21, 1-50.
8. Carolei, A., Fieschi, C., Bruno, R., and Toffano, G. (1991). Monosialoganglioside GM1 in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 3, 134-157.
9. Schneider, J. S., Pope, A., Simpson, K., Taggart, J., Smith, M. G., and DiStefano, L. (1992). Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Science 256, 843-846.
10. Herrero, M. T., Perez-Otano, I., Oset, C., Kastner, A., Hirsch, E. C., Agid, Y., Liquin, M. R., Obeso, J. A., and Del Rio, J. (1993). GM1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience 56, 965-972.
11. Liberini, P., Pioro, E. P., Maysinger, D., Ervin, F.R., and Cuello, A. C. (1993). Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction. Neuroscience 53, 625-637.
12. Walker, J. B., and Harris, M. (1993). GM-1 ganglioside administration combined with physical theapy restores ambulation in humans with chronic spinal cord injury. Neurosci. Lett. 161, 174-178.
13. Dalia, A., Neff, N. H., and Hadjiconstantinou, M. (1993). GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+. J. Neurosci. 13, 3104-3111.
14. Tan, W. K., Williams, C. E., Mallard, C. E., and Gluckman, P. D. (1994). Monosialoganglioside GM1 treatment after a hypoxic-ischemic episode reduces the vulnerability of the fetal sheep brain to subsequent injuries. Am. J. Obstet. Gynecol. 170, 663-669.
15. Schneider, J. S. (1994). The therapeutic role of gangliosides in neurological disorders. CNS Drugs 3, 213-222.
16. Nobile-Orazio, E., Carpo, M., and Scarlato, G. (1994). Gangliosides. Their role in clinical neurology. Drugs 47, 576-585.
17. Geisler, F. H., Dorsey, F. C., and Coleman, W. P. (1993). Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann. Emerg. Med. 22, 1041-1047.
18. Ledeen, R. W. (1983). Gangliosides. In: Handbook of Neurochemistry, vol. 3, (Lajtha, A., ed.), Plenum, New York, pp. 41-90.
19. Wiegandt, H. (1982). The gangliosides. Adv. Neurochem. 4, 149-223.
20. Svennerholm, L. (1984). Biological significance of gangliosides. In: Cellular and Pathological Aspects of Glycoconjugate Metabolism, vol. 125 (Dreyfus, H., Massarelli, R., Freysz, L., and Rebel, G., eds.) INSERM, Paris, pp. 21-44.
21. Hakomori, S. (1981). Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Annu. Rev. Biochem. 50, 733-764.
22. Ledeen, R. W. (1985). Gangliosides of the neuron. Trends Neurosci. 8, 169-174.
23. Rosner, H., and Rahmann, H. (1987). Ontogeny of vertebrate brain gangliosides. In: Gangliosides and Modulation of Neuronal Function. NATO ASI Series, vol. H7, (Rahmann, H., ed.), Springer-Verlag, Berlin, pp. 373-390.
24. Tettamanti, G., Sonnino, S., Ghidoni, R., Masserini, M., and Venerando, B. (1985). Chemical and functional properties of gangliosides. Their possible implication in the membrane-mediated transfer of information. In: Physics of Amphiphiles: Micelles, Vesicles and Microemulsions, (de Giorgio, V., and Corti, M., eds.), XC Corso Societ. Italiana di Fisica, Bologna, pp. 607-636.
25. Fishman, P. H. (1982). Role of membrane gangliosides in the binding and action of bacterial toxins. J. Membr. Biol. 69, 85-97.
26. Facci, L., Leon, A., Toffano, G., Sonnino, S., Ghidoni, R., and Tettamanti, G. (1984). Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J. Neurochem. 42, 299-305.
27. Roisen, F. J., Bartfeld, H., Nagele, R., and York, G. (1981). Ganglioside stimulation of axonal sprouting in vitro. Science 214, 577-578.
28. Leon, A., Facci, L., Benvegnu, D., and Toffano, G. (1983). Morphological and biochemical effects of gangliosides in neuroblastoma cells. Dev. Neurosci. 5, 108-114.
29. Ledeen, R. W., Wu, G., Cannella, M. S., Oderfeld-Nowak, B., and Cuello, A. C. (1990). Gangliosides as neurotrophic agents: Studies on the mechanism of action. Acta Neurobiol. Exp. 50, 439-449.
30. Wu, G., and Ledeen, R. W. (1991). Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: Putative role of GM1 ganglioside in differentiation. J. Neurochem. 56, 95-104.
31. Ferrari, G., Fabris, M., and Gorio, A. (1983). Gangliosides enhance neunte outgrowth in PC12 cells. Dev. Brain Res. 8, 215-221.
32. Katoh-Semba, R., Skaper, S. D., and Varon, S. (1984). Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum and NGF-dependent effects on neuritic growth (and proliferation). J. Neurosci. Res. 12, 299-310.
33. Skaper, S.D., Katoh-Semba, R., and Varon, S. (1985). GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions. Dev. Brain Res. 23, 19-26.
34. Spoerri, P. E., and Roisen, F. J. (1988). Ganglioside potentiation of NGF-independent trophic agents on sensory ganglia. Neurosci. Lett. 90, 21-26.
35. Leon, A., Benvegnu, D., Dal Toso, R., Presti, D., Facci, L., Giorgi, O., and Toffano, G. (1984). Dorsal root ganglia and nerve growth factor: A model for understanding the mechanism of GM1 effects on neuronal repair. J. Neurosci. Res. 12, 277-287.
36. Doherty, P., Dickson, J. G., Flanigan, T. P., and Walsh, F. S. (1985). Ganglioside GM1 does not initiate, but enhances neurite regeneration of nerve growth factor-dependent sensory neurons. J. Neurochem. 44, 1259-1265.
37. Spoerri, P. E. (1986). Facilitated-establishment of contacts and synapses in neuronal cultures: ganglioside-mediated neurite sprouting and outgrowth. In: Gangliosides and Neuronal Plasticity (Tettamanti, G., Ledeen, R. W., Sandhoff, K., Nagai, Y., and Toffano, G., eds.), Fidia Research Series, vol. 6, Liviana, Padua, pp. 309-325.
38. Canella, M. S., Oderfeld-Nowak, B., Gradkowska, M., Skup, M., Garofalo, L., Cuello, A. C., and Ledeen, R. W. (1990). Derivatives of gangliosides as neurotrophic agents: Comparison of in vivo and in vitro effects. Brain Res. 513, 286-294.
39. Schwartz, M., and Spirman, N. (1982). Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies. Proc. Natl. Acad. Sci. USA 79, 6080-6083.
40. Leon, A., Dal Toso, R., Presti, D., Benvegnu, D., Facci, L., Kirschner, G., Tettamanti, G., and Toffano, G. (1988). Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides. J. Neurosci. 8, 746-753.
41. Ferrari, G., Batistatou, A., and Greene, L. A. (1993). Gangliosides rescue neuronal cells from death after trophic factor deprivation. J. Neurosci. 13, 1879-1887.
42. De Cristian, G., Morbidelli, L., Alessandri, G., Ziche, M., Cappa, A. P. M., and Gullino, P. M. (1990). Synergism between gangliosides and basic fibroblastic growth factor in favoring survival, growth, and motility of capillary endothelium. J. Cell Physiol. 144, 505-510.
43. Garofalo, L., and Cuello, A. C. (1994). Nerve growth factor and the monosialoganglioside GM1: Analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Exp. Neurol. 125, 195-217.
44. Garofalo, L., Ribeiro-Da-Silva, A., and Cuello, A. C. (1993). Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1. Neuroscience 57, 21-40.
45. Vantini, G., Fusco, M., Bigon, E., and Leon, A. (1988). GM1 ganglioside potentiates the effect of nerve growth factor in preventing vinblastine-induced sympathectomy in newborn rats. Brain Res. 448, 252-258.
46. Choi, D. W., and Rothman, S. M. (1990). The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182.
47. Cheng, B., and Mattson, M. P. (1991). NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7, 1031-1041.
48. Cheng, B., and Mattson, M. P. (1992). IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12, 1558-1566.
49. Skaper, S. D., Leon, A., and Facci, L. (1993). Basic fibroblast growth factor modulates sensitivity of cultured hippocampal pyramidal neurons to glutamate cytotoxicity: Interaction with ganglioside GM1. Dev. Brain Res. 71, 1-8.
50. Skaper, S. D., Facci, L., Schiavo, N., Vantini, G., Moroni, F., Dal Toso, R., and Leon, A. (1992). Characterization of 2,4,5-trihydroxyphenylalanine neurotoxicity in vitro and protective effects of ganglioside GM1: Implications for Parkinson's disease. J. Pharmacol. Exp. Ther. 263, 1440-1446.
51. Batistatou, A., and Greene, L. A. (1991). Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J. Cell Biol. 115, 461-471.
52. Batistatou, A., and Greene, L. A. (1993). Internucleosomal DNA cleavage and neuronal cell survival/death. J. Cell Biol. 122, 523-532.
53. Edwards, S. N., Buckmaster, A. E., and Tolkovsky, A. M. (1991). The death program in cultured sympathetic neurons can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J. Neurochem. 57, 2140-2143.
54. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
55. Deckwerth, T. L., and Johnson, E. M., Jr. (1993). Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor (NGF). J. Cell Biol. 123, 1207-1222.
56. Greene, L. A. (1978). Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78, 747-755.
57. Rukenstein, A., Rydel, R. E., and Greene, L. A. (1991). Multiple agents rescue PC12 cells from serum-free cell death by translation-and transcription-independent mechanisms. J. Neurosci. 11, 2552-2563.
58. Ferrari, G., Anderson, B. L., Stephens, R. M., Kaplan, D. R., and Greene, L. A. (1995). Prevention of apoptotic neuronal death by GM1 ganglioside: Involvement of Trk neurotrophin receptors. J. Biol. Chem. 270, 3074-3080.
59. Loeb, D. M., Maragos, J., Martin-Zanca, D., Chao, M. V., Parada, L. F., and Greene, L. A. (1991). The trk proto-oncogene rescues NGF responsiveness in mutant NGF-responsive PC12 cell lines. Cell 66, 961-966.
60. Loeb, D. M., and Greene, L. A. (1993). Transfection with trk restores "slow" NGF binding, efficient NGF uptake, and multiple NGF responses to NGF-non responsive PC12 cell mutants. J. Neurosci. 13, 2919-2929.
61. Kaplan, D. K., Martin-Zanca, D., and Parada, L. F. (1991). Tyrosine phosphorylation and tyrosine kinase activity of the trk oncogene product induced by NGF. Nature 350, 158-160.
62. Klein, R., Jing, S., Nanduri, V., O'Rourke, E., and Barbacid, M. (1991). The trk protooncogene encodes a receptor for nerve growth factor. Cell 65, 189-197.
63. Ferrari, G., Fabris, M., Fiori, M. G., Gabellini, N., and Volonté, C. (1992). Gangliosides prevent the inhibition by K-252a of NGF responses in PC12 cells. Dev. Brain Res. 65, 35-42.
64. Green, S., Rydel, R. E., Conolly, J. L., and Greene, L. A. (1986). PC12 mutants possessing low- but not high-affinity NGF receptors neither respond to, nor internalize NGF. J. Cell. Biol. 102, 830-843.
65. Jing, S., Tapley, P., and Barbacid, M. (1992). Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9, 1076-1079.
66. Ullrich, A., and Schlessinger, J. (1992). Signal transduction by receptors with tyrosine kinase activity. Neuron 9, 1067-1079.
67. Skaper, S. D., Negro, A., Dal Toso, R., and Facci, L. (1993). Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neurosensitivity to excitotoxin damage: Synergistic effects of monosialogangliosides. J. Neurosci, Res. 33, 330-337.